Dotmatics

Scripps News America Tonight

In a Scripps News America Tonight feature, Phil Mounteney, VP of Science and Technology at Dotmatics, discusses how Dotmatics Luma leverages artificial intelligence to transform scientific research and pharmaceutical drug discovery by accelerating innovation, reducing costs, and shortening time-to-market for modern laboratories.

Scripps News America Tonight

Latest Blogs

Case Studies

White Papers

Upcoming Events

News

Search

Scripps News 6-25-24 Phil Mounteney

Press O for more options

Video Thumbnail

Video Thumbnail

Click for sound

5:12


In this feature from Scripps News America Tonight, Phil Mounteney, Vice President of Science and Technology at Dotmatics, explores how artificial intelligence (AI) is revolutionizing scientific research and pharmaceutical drug discovery. Discover how Dotmatics Luma harnesses AI to accelerate innovation, cut costs, and reduce time-to-market, addressing the complex challenges faced by modern laboratories.

Learn More About Dotmatics

Meet with a product expert to see how Dotmatics uses AI technologies to drive down the cost of drug discovery.

Request a Demo of Dotmatics